Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
Pfizer Inc. presented detailed results from an ongoing phase 2 study investigating tilrekimig (PF-07...
Read story
Clear Scientific, Inc. today announced positive top-line results from its Phase 2 trial of CS-1103,...
Read story
AnnJi Pharmaceutical Co., Ltd. (AnnJi, TPEx: 7754), a clinical-stage drug development company focuse...
Read story
Takeda announced new data from three phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279), an...
Read story
Agreement Gives Tolerance Bio Worldwide Development Rights Outside Japan Tolerance Bio, Inc. has...
Read storyPage 1 of 2